Skip to main content
. 2020 Aug 25;11:4078. doi: 10.1038/s41467-020-17930-x

Fig. 5. Blood replacement therapy alters cytokine panel in the plasma of stroke mice.

Fig. 5

Naive mice (8~12 months old males) serve as a control group (circles, n = 6). Stroke mice (8~12 months old males) underwent tMCAO for 90 min. The occlusion and reperfusion were confirmed by a laser speckle imager. Stroke mice were then randomized into four groups: two groups being killed at 8 (squares, n = 6) and 23 h (diamonds, n = 6) post stroke; two groups receiving blood replacement (BR) therapy and being killed at 8 (down-pointing triangles, n = 6) and 23 h (up-pointing triangles, n = 6) post stroke. Then plasma was collected for the analyses of proinflammatory cytokine panel including IL-1β, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12, IFN-γ, TNF-α, and the chemokine, CXCL1. Data were presented as means ± SEM. One-way ANOVA followed by post hoc Fisher’s unprotected least-significant difference for multiple comparison tests. Source data are provided as a Source Data file.